Urokinase inhibits HL-60 cell proliferation in vitro

Blood Coagul Fibrinolysis. 1994 Aug;5(4):445-53.

Abstract

The binding of urokinase-type plasminogen activator (u-PA) to its receptor (u-PA-R) is required for morphological and functional maturation during monocyte differentiation of the promyelocytic leukaemia line HL-60. This paper reports that monocyte differentiation of HL-60 cells induced by 1,25 dihydroxyvitamin D2 (vitamin D2) results in a marked increase in expression of u-PA and u-PA-R. This increase in u-PA expression is of greater magnitude than is observed after culture with interferon-gamma (IFN gamma), another potent inducer of monocytic differentiation. Dimethyl sulphoxide (DMSO), an agent that induces granulocytic differentiation, also increased expression of u-PA. However, culture with the granulocyte-inducing all-trans retinoic acid (RA) did not induce an increase in surface expression of u-PA or u-PA-R. The vitamin D2-induced increase in cell-surface u-PA was not coincident with an increase in steady-state levels of u-PA mRNA, suggesting that intracellular stores of this protein, translational or post-translational mechanisms of regulation, or some other regulatory mechanism may be responsible for the increase in u-PA during differentiation. To ascertain an association between the increased expression of cell-surface u-PA and reduced proliferation that accompanies differentiation, the effect of u-PA on cellular proliferation of HL-60 cells was measured. Both pro-u-PA (whole molecule) and fragments of u-PA that retained receptor-binding capability caused a marked inhibition of HL-60 proliferation in the absence of vitamin D2.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Autoreceptors / drug effects
  • Binding Sites
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Depression, Chemical
  • Dimethyl Sulfoxide / pharmacology
  • Ergocalciferols / pharmacology
  • Gene Expression Regulation, Leukemic / drug effects
  • Growth Substances / pharmacology
  • Humans
  • Interferon-gamma / pharmacology
  • Leukemia, Promyelocytic, Acute / pathology*
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Peptide Fragments / pharmacology
  • RNA, Messenger / metabolism
  • RNA, Neoplasm / metabolism
  • Receptors, Cell Surface / biosynthesis
  • Receptors, Cell Surface / genetics
  • Receptors, Urokinase Plasminogen Activator
  • Recombinant Proteins / pharmacology
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Up-Regulation / drug effects
  • Urokinase-Type Plasminogen Activator / metabolism
  • Urokinase-Type Plasminogen Activator / pharmacology*

Substances

  • Autoreceptors
  • Ergocalciferols
  • Growth Substances
  • Neoplasm Proteins
  • PLAUR protein, human
  • Peptide Fragments
  • RNA, Messenger
  • RNA, Neoplasm
  • Receptors, Cell Surface
  • Receptors, Urokinase Plasminogen Activator
  • Recombinant Proteins
  • Tretinoin
  • Interferon-gamma
  • Urokinase-Type Plasminogen Activator
  • saruplase
  • Dimethyl Sulfoxide